Connection

KETANKUMAR GHAGHADA to Xenograft Model Antitumor Assays

This is a "connection" page, showing publications KETANKUMAR GHAGHADA has written about Xenograft Model Antitumor Assays.
  1. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
    View in: PubMed
    Score: 0.037
  2. Effect of Dose and Selection of Two Different Ligands on the Deposition and Antitumor Efficacy of Targeted Nanoparticles in Brain Tumors. Mol Pharm. 2019 10 07; 16(10):4352-4360.
    View in: PubMed
    Score: 0.033
  3. A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma. Sci Rep. 2017 12 19; 7(1):17751.
    View in: PubMed
    Score: 0.030
  4. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle. Cancer Res. 2015 Apr 01; 75(7):1356-65.
    View in: PubMed
    Score: 0.024
  5. Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget. 2011 Apr; 2(4):298-304.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.